Posted on December 5, 2018December 7, 2018 by Pulse AssentISO/TS 20399-1:2018 Biotechnology. Ancillary materials present during the production of cellular therapeutic products General requirements Link: ISO/TS 20399-1:2018 Biotechnology. Ancillary materials present during the production of cellular therapeutic products General requirements Source: BSI Standards Related Posts:New laws to introduce digital labelling for…UK Government announces extension of CE mark…Expert regional innovation hubs given £75 million…Government puts business first with Brexit…UK Export Finance unveils extra support for SME exporters
